Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 6,723 shares at $28.44 ($192K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $192k DNLI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.44 | 2,636 | $75K | 39.1% |
| 2 | $28.44 | 2,636 | $75K | 39.1% |
| 3 | $28.67 | 1,451 | $42K | 21.7% |
| Total | $28.49 avg | 6,723 | $192K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |